VA

VR Adviser Portfolio holdings

AUM $2.02B
1-Year Est. Return 169.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+169.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.78B
AUM Growth
+$442M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1 +$20.8M
2 +$20.1M
3 +$19.6M
4
SVRA icon
Savara
SVRA
+$11.2M
5
OCUL icon
Ocular Therapeutix
OCUL
+$4.77M

Top Sells

1 +$47.1M
2 +$30.5M
3 +$17.5M
4
ELVN icon
Enliven Therapeutics
ELVN
+$16.1M
5
COGT icon
Cogent Biosciences
COGT
+$8.95M

Sector Composition

1 Healthcare 99.55%
2 Financials 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
1
Apogee Therapeutics
APGE
$4.99B
$337M 18.99%
8,493,321
MTSR
2
DELISTED
Metsera Inc
MTSR
$196M 11.05%
3,750,662
OCUL icon
3
Ocular Therapeutix
OCUL
$2.24B
$154M 8.66%
13,161,462
+399,000
CDTX
4
DELISTED
Cidara Therapeutics
CDTX
$90.7M 5.1%
946,788
+307,700
VRDN icon
5
Viridian Therapeutics
VRDN
$2.9B
$83.8M 4.72%
3,882,709
KALV icon
6
KalVista Pharmaceuticals
KALV
$820M
$82M 4.61%
6,728,985
ORKA
7
Oruka Therapeutics
ORKA
$1.6B
$79.8M 4.49%
4,148,428
ORIC icon
8
Oric Pharmaceuticals
ORIC
$1.54B
$79.2M 4.46%
6,596,885
ELVN icon
9
Enliven Therapeutics
ELVN
$1.75B
$66M 3.72%
3,226,331
-800,000
COGT icon
10
Cogent Biosciences
COGT
$6.02B
$57.4M 3.23%
4,000,000
-755,411
CTMX icon
11
CytomX Therapeutics
CTMX
$793M
$49.6M 2.79%
15,561,500
+1,591,618
ABVX
12
Abivax
ABVX
$8.65B
$49M 2.76%
576,729
-769,051
SVRA icon
13
Savara
SVRA
$1.07B
$45.3M 2.55%
12,681,043
+3,796,780
SYRE icon
14
Spyre Therapeutics
SYRE
$3.15B
$45M 2.53%
2,685,448
ERAS icon
15
Erasca
ERAS
$4.79B
$38.9M 2.19%
17,857,083
DNTH icon
16
Dianthus Therapeutics
DNTH
$2.82B
$37.8M 2.13%
960,803
-39,197
ENGN icon
17
enGene Holdings
ENGN
$581M
$34.5M 1.94%
5,046,414
MAZE
18
Maze Therapeutics
MAZE
$2.16B
$31.9M 1.8%
+1,230,769
JBIO
19
Jade Biosciences
JBIO
$693M
$27.8M 1.56%
3,220,364
DYN icon
20
Dyne Therapeutics
DYN
$2.45B
$27.5M 1.55%
2,173,913
VOR icon
21
Vor Biopharma
VOR
$628M
$24.4M 1.37%
+499,966
UPB
22
Upstream Bio Inc
UPB
$414M
$22M 1.24%
1,169,298
-1,126,021
ZURA icon
23
Zura Bio
ZURA
$661M
$20.1M 1.13%
4,631,216
ATXS
24
DELISTED
Astria Therapeutics
ATXS
$17.9M 1.01%
2,457,348
PHVS icon
25
Pharvaris
PHVS
$1.68B
$16.8M 0.95%
674,599
-1,373,021